Torrent Pharmaceuticals (NSE:TORNTPHARM) Tax Provision: ₹-7,110 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:TORNTPHARM Torrent Pharmaceuticals Ltd NSE:TORNTPHARM
88 GF Score
Price ₹4,914.50
GF Value ₹4,554.27
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Torrent Pharmaceuticals Tax Provision?

Torrent Pharmaceuticals NSE:TORNTPHARM +0.44% 88 Tax Provision is ₹-7,110 Mil as of Jun. 2026. GuruFocus rates NSE:TORNTPHARM with a GF Score™ of 88/100 and a GF Value™ of ₹4,554.27 (Fairly Valued). The stock has 7 warning signs investors should review.

Torrent Pharmaceuticals's tax provision for the three months ended in Jun. 2026 was ₹-1,670 Mil. Its tax provision for the trailing twelve months (TTM) ended in Jun. 2026 was ₹-7,110 Mil.

Torrent Pharmaceuticals Tax Provision Historical Data

* Premium members only.

The historical data trend for Torrent Pharmaceuticals's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Torrent Pharmaceuticals Tax Provision Chart

Torrent Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,487.30 -6,019.30 -6,957.30 -7,615.60 -7,340.10

Torrent Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,900.00 -2,000.00 -1,790.00 -1,650.00 -1,670.00
NSE:TORNTPHARM
88GF Score
Torrent Pharmaceuticals Ltd NSE:TORNTPHARM
Tax Provision is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Torrent Pharmaceuticals Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-7,110 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of ₹-7,110 Mil mean?
Torrent Pharmaceuticals (NSE:TORNTPHARM) has a Tax Provision of ₹-7,110 Mil as of Jun. 2026. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Torrent Pharmaceuticals and its competitors.
Is Torrent Pharmaceuticals' Tax Provision too high?
Torrent Pharmaceuticals' current Tax Provision is ₹-7,110 Mil. Overall, Torrent Pharmaceuticals has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Torrent Pharmaceuticals' Tax Provision compare to ZTS?
Torrent Pharmaceuticals' Tax Provision of ₹-7,110 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Drug Manufacturers company?
A good Tax Provision depends on the Drug Manufacturers industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Torrent Pharmaceuticals and its competitors. Torrent Pharmaceuticals's current Tax Provision is ₹-7,110 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Torrent Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Torrent Pharmaceuticals (NSE:TORNTPHARM) is currently considered Fairly Valued. The stock's GF Value™ is ₹4,554.27, compared to a current price of ₹4,914.50 — trading 7.9% above its estimated fair value. The current Tax Provision is ₹-7,110 Mil. Torrent Pharmaceuticals' overall GF Score™ is 88/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For Torrent Pharmaceuticals (NSE:TORNTPHARM), the current Tax Provision is ₹-7,110 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Torrent Pharmaceuticals stock appears to be overvalued. The current stock price of ₹4,914.50 is trading 7.9% above its estimated GF Value™ of ₹4,554.27. GuruFocus considers Torrent Pharmaceuticals to be Fairly Valued.

Key valuation signals for NSE:TORNTPHARM:

  • Tax Provision: ₹-7,110 Mil
  • GF Value™: ₹4,554.27 vs. price of ₹4,914.50 (7.9% above fair value)
  • GF Score™: 88/100 with 7 warning signs

No single metric tells the full story. See the NSE:TORNTPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Torrent Pharmaceuticals Business Description

Other Exchanges 500420:India
Address Off Ashram Road, Torrent House, Ahmedabad, GJ, IND, 380009
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, Vitamins Minerals Nutrients (VMN), and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.
88GF Score

Get the complete analysis for NSE:TORNTPHARM

Tax Provision is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4,914.50
Price
₹4,554.27
GF Value